Status:
WITHDRAWN
To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Acute Liver Failure
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
All patients of Acute liver failure not meeting the KCH (King's College Hospital) criteria/or meeting KCH criteria not having option of liver transplant will be recruited for the trial. The first grou...
Eligibility Criteria
Inclusion
- Acute liver failure -Not meeting KCH Criteria/Meeting KCH Criteria but not having Liver transplant option
Exclusion
- Culture Positive Sepsis
- History of taking lactulose, rifaximin, neomycin, metronidazole, L-Ornithine L-Aspartate
- Receiving psychoactive drugs, promotility and hypomotility drugs
- Pregnant females
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03363022
Start Date
February 1 2020
End Date
December 31 2020
Last Update
November 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India, 110070